Platelet and endothelial function tests during metformin treatment in diabetes mellitus (short communication).
D015121:6-Ketoprostaglandin F1 alpha / Q000097:blood; D000368:Aged; D000941:Antigens / Q000032:analysis; D001792:Blood Platelets / Q000187:drug effects / Q000502:physiology*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000503:physiopathology*; D004727:Endothelium / Q000187:drug effects / Q000502:physiology*; D005169:Factor VIII / Q000032:analysis / Q000276:immunology; D005260:Female; D005905:Glyburide / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008687:Metformin / Q000627:therapeutic use*; D008875:Middle Aged; D010974:Platelet Aggregation / Q000187:drug effects; D013929:Thromboxane B2 / Q000097:blood; D001620:beta-Thromboglobulin / Q000378:metabolism; D014841:von Willebrand Factor / Q000032:analysis
D000941:Antigens; D001620:beta-Thromboglobulin; D014841:von Willebrand Factor; D013929:Thromboxane B2; D015121:6-Ketoprostaglandin F1 alpha; D005169:Factor VIII; D008687:Metformin; D005905:Glyburide